Enovis Corporation Market Research Report

Company Overview

• Name: Enovis Corporation

• Mission: Enovis is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life.

• Founded: 1995 as Colfax Corporation. It rebranded to Enovis in 2022.

• Founders: Steven and Mitchell Rales

• Key People:

• Matthew L. Trerotola, Chair and Chief Executive Officer

• Ben Berry, Chief Financial Officer

• Brady R. Shirley, President and Chief Operating Officer

• Daniel A. Pryor, Executive Vice President, Strategy and Business Development

• Patricia Lang, Senior Vice President and Chief Human Resources Officer

• Bradley J. Tandy, Senior Vice President and Chief Legal Officer

• Terry Ross, Group President, Prevention & Recovery

• Louie Vogt, Group President, Reconstructive

• Headquarters: 2711 Centerville Road, Suite 400, Wilmington, DE 19808

• Number of Employees: 8,000+ employees located across six continents.

• Revenue: Full-year revenue for 2024 is estimated at $2.10 billion.

• Known For: Innovation-driven medical technology solutions that generate measurably better patient outcomes.

Products

DonJoy® Defiance® Pro

• Description: Premier knee brace for injury prevention and recovery.

• Key Features: Offers superior protection and support, customizable fit.

Altivate Reverse® Glenoid

• Description: Part of a shoulder implant system.

• Key Features: Revolutionary design offering stable and lasting shoulder replacement functionality.

Shockwave Therapy

• Description: An advanced method for tissue therapy.

• Key Features: Treats deeper, faster, and easier with cutting-edge technology.

ARVIS® Augmented Reality System

• Description: Wearable, self-contained augmented reality surgical guidance system.

• Key Features: Real-time, hands-free guidance for hip and knee surgeries.

DynaNail® Helix

• Description: A dynamic compression nail.

• Key Features: Provides compression using NiTiNOL technology, available in various options for insertion flexibility.

Motion iQ®

• Description: A platform enabling enhanced rehabilitation.

• Key Features: Patient-centric approach with a focus on improved recovery and compliance.

40W LightForce® XLi Therapy Laser

• Description: High-powered laser therapy device.

• Key Features: Delivers fast, effective treatments with intelligent power management.

MotionMD®

• Description: Platform designed to automate DME workflows.

• Key Features: Enhances patient experience, simplifies inventory management, promotes compliance.

Recent Developments

• Financial Results Q3 2024: Enovis reported third-quarter net sales of $505 million, showing a 21% growth on a reported basis compared to the same quarter in 2023.

• Center of Excellence: Opened a new ceramics plant in Mörsdorf, Germany, to enhance production capabilities and support orthopedic surgeons globally, doubling production capacity.

• Partnerships: Strategic partnership with Ossium Health for the distribution of OssiGraft™ and OssiGraft Prime™ announced in October 2024.

• Leadership Appointments: Tim Czartoski was appointed as President, U.S. Surgical and Global Product and Enabling Technologies in September 2024.

• Product Launches: Introduction of a broad spectrum of new product innovations across all business areas.

Conclusion

Enovis Corporation continues to cement its position as a leading figure in medical technology innovation. With recent initiatives aimed at global expansion, innovative product introductions, and forming strategic partnerships, the company is poised for substantial growth. Its commitment to improving patient outcomes and advancing healthcare technology remains at the forefront of its business strategy.